title: Deferoxamine for the diagnosis and treatment of aluminum-associated osteodystrophy.
authors.affiliation: INSERM U. 234, Lyon, France.
authors.forename: S
authors.initials: S
authors.lastname: Charhon
authors.forename: S
authors.initials: S
authors.lastname: el Yafi
authors.forename: M
authors.initials: M
authors.lastname: Gaillard
authors.forename: M
authors.initials: M
authors.lastname: Beruard
authors.forename: G
authors.initials: G
authors.lastname: Janin
authors.forename: M
authors.initials: M
authors.lastname: Accominotti
authors.forename: J
authors.initials: J
authors.lastname: Traeger
authors.forename: P J
authors.initials: PJ
authors.lastname: Meunier
mesh_terms: D000328:Adult; D000535:Aluminum / Q000009:adverse effects* / Q000097:blood / Q000378:metabolism; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D003676:Deferoxamine / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D010281:Parathyroid Hormone / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects
chemical_list: D010281:Parathyroid Hormone; D000535:Aluminum; D003676:Deferoxamine